Lofwall, M. R., Walsh, S. L., Nunes, E. V., Bailey, G. L., Sigmon, S. C., Kampman, K. M., . . . Kim, S. (2018). Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial. JAMA Intern Med.
Citación estilo ChicagoLofwall, Michelle R., et al. "Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations Vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial." JAMA Intern Med 2018.
Cita MLALofwall, Michelle R., et al. "Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations Vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial." JAMA Intern Med 2018.